98092280 - SYN.AI

Information

• Trademark
• 98092280

• Source

• Serial Number

  98092280

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 35 - Advertising
  • 39 - Transport
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 19, 2023
  a year ago

• Transaction Date

  August 05, 2024
  a month ago

• Status Date

  August 05, 2024
  a month ago

• Location Date

  June 27, 2024
  2 months ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  KING, LINDA M

• Attorney Docket Number

  MGI0104TUS

  Attorney Name

  Michelle P. Ciotola

  Law Office Assigned Location Code

  M70

• Owners

  • SYNGENE INTERNATIONAL LTD

Case File Statements

• GS0401: Treatment of materials by polymerization; custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, medicines, drugs by pharmaceutical compounders; contract manufacturing in the field of pharmaceuticals and drug development
• GS0391: Biomedical services, namely, the storage of human cells for medical use
• GS0051: Biological and bio-technological pharmaceutical preparations for the treatment of inflammation, metabolic disorders, oncology/immune-oncology, central nervous system disorders, pain and cardiovascular and renal disorders, anti-infective and fibrosis treatments, ophthalmic disorders; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for medical purposes; synthetic peptides for pharmaceutical purposes for the treatment of inflammation, metabolic disorders, oncology/immune-oncology, central nervous system disorders, pain and cardiovascular and renal disorders, anti-infective and fibrosis treatments, ophthalmic disorders; aldehydes for pharmaceutical purposes; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; vascular grafts; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; protein arrays for medical diagnostic purposes; medicines for veterinary purposes for the treatment of inflammation, metabolic disorders, oncology/immune-oncology, central nervous system disorders, pain and cardiovascular and renal disorders, anti-infective and fibrosis treatments, ophthalmic disorders; isotopes for medical purposes; biological preparations for use in cell cultures for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
• GS0161: Paper and paper products, namely, file cards, blank cards, placards, printed cards, industrial papers, notebook papers; cardboard and cardboard packaging; printed matter, namely, newspapers, periodicals and books in the field of clinical medicine, medical writing and pharmacovigilance services; bookbinding materials for creating hardcover books, namely, book covers, crack-and-peel binding paper, reinforcement strips, peel-and-stick labels, stapler and staples; photographs; stationery; adhesives for stationery; artists' materials, namely, artists' brushes and drawing material, namely, drawing instruments and drawing pads; paint brushes; typewriters and office requisites other than furniture, namely, staplers, staple removers, paper trimmers, rubber bands, correcting tape, adhesive tape dispensers; printers type and printing clichés; printed directories in the field of clinical medicine, medical writing and pharmacovigilance services; blank writing journals; printed instructional and teaching materials in the field of clinical medicine, medical writing and pharmacovigilance services
• GS0351: Business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, large molecule development, antibody drug conjugates and clinical development services; consulting services in the field of medical practice management for others; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business management consulting services in the field of pharmaceuticals drug development
• GS0011: Bio-technological products, namely, enzymes for scientific and research purposes, protein for industrial use, carbohydrates used as an ingredient in the manufacture of nutraceuticals, lipids used in the manufacture of cosmetics, beverages, food products and food supplements, and nucleic acids for scientific purposes, DNA products, namely, DNA polymerase, DNA polymerase formulations, immunological re-agents for scientific purposes, and fine industrial chemicals featuring organic intermediates; active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammation, metabolic disorders, oncology/immune-oncology, central nervous system disorders, pain and cardiovascular and renal disorders, anti-infective and fibrosis treatments, ophthalmic disorders; chemicals for use in the agrochemical industry; assays for research purposes; biomedical compounds, namely, peptide substrates used in analysing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; unprocessed chemical polymers; chemicals for use in biotechnological product development; chemicals, namely, chitosan; chemicals, namely, chitosan for industrial purposes; aldehydes; chromatography chemicals; cells for scientific, laboratory or medical research; reagents for scientific use in the development of hybridoma antibodies, other than for medical or veterinary purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; protein arrays and nucleotide arrays for scientific and medical research; peptides substrates for industrial purposes; proteins for industrial use in recombinant DNA technology, other than for medical use; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; chemicals for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; assays for research purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical preparations for use in DNA analysis in laboratories, other than for medical or veterinary purposes; proteins for use in recombinant DNA technology
• GS0441: Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services
• GS0101: Surgical instruments and apparatus for medical, dental or veterinary use; artificial limbs, eyes and teeth
• GS0421: Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing of materials; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; chemical analysis; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; scientific research in the nature of conducting clinical trials; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific research services relating to the isolation and cultivation of human tissues and cells; preparation of reports relating to scientific and technical research; biochemical analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific laboratory services; services of a chemical or biological scientific laboratory; laboratory research services relating to pharmaceuticals; scientific research and development and scientific research consultation in the fields of antibodies, antibody technology, chemistry, agrochemical pharmaceuticals, bioinformatics, biomedical, biologics, biotechnology, bio therapeutics, biology, biochemical, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, solid state characterization; toxicokinetic, toxicology; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the fields of antibody, API, biomolecules, cell bank characterization, chiral, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbial, monomer, nano particle, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines

Case File Event Statements

• 7/22/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/17/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/25/2024 - 5 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/27/2024 - 2 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/27/2024 - 2 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/27/2024 - 5 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/27/2024 - 5 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/27/2024 - 5 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/5/2024 - a month ago

  11 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/5/2024 - a month ago

  12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/5/2024 - a month ago

  10 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/27/2024 - 2 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA